London Tour Operators See Shifting Demand From Landmark Tours to HighSpeed Thames Rides Kevin Warsh Faces Divided FOMC Over Rate Cut Path as Inflation and Yields Rise UKGulf Trade Deal Hailed as Monumental Achievement by Bahrain Minister Secretary of State Rubio Discusses US Energy Sales With Indias Modi Amid Iran Conflict Disruptions Tulsi Gabbard Steps Down as Intelligence Chief to Focus on Family Health How Big Tech Influenced Trumps Reversal on AI Safety Executive Order Hycroft Mining Holding Corporation HYMC Q3 2025 Earnings Narrower Loss Signals Progress in Cost Discipline CIT Inc Q1 2026 Earnings EPS Misses Estimates Amid Market Caution PLCE Q1 2026 Earnings EPS Misses by Wide Margin as Headwinds Persist Braze Inc Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction PPBT Q1 2025 Earnings Narrowing Losses and Pipeline Progress Drive Optimism Savers Value Village SVV Q1 2026 Earnings EPS Falls Just Short of Estimates Shares Rally IT Tech Packaging ITP Slips Further as Stock Navigates Narrow Range Near Support Levels FUL Shows Modest Gains as Speciality Chemicals Sector Finds Footing Pioneer Bancorp Inc PBFS Shows Mild Uptick Amid Consolidation Above Key Support GigCapital9 Corp Rights GIXXR Hold Steady at 032 as Support and Resistance Levels Tighten ATA Creativity Global AACG Sees Modest Decline Tests Key Support at 110 Mizuho Maintains Outperform Rating on ON Semiconductor Raises Price Target on AI Tailwinds MCS Q1 2026 Earnings NarrowerThanExpected Loss Lifts Investor Sentiment Core Scientific Warrants CORZW Surge Over 5 Key Levels to Watch Cheer Holding Inc CHR Surges 663 Breaking Through Resistance or Temporary Bounce Cinemark Holdings CNK Holds Near Key Support Amid Modest Decline Upstart Holdings Surges 79 Bulls Test Key Resistance After AIPowered Lending Optimism Palantir Technologies PLTR Dips 2 Support and Resistance Levels in Focus BEST SPAC I Acquisition Corp Rights BSAAR Holds at 014 Minimal Movement Reflects Low Liquidity ServiceTitan TTAN Gains 3 as Stock Approaches Key Resistance Level AgomAb Therapeutics AGMB Gains 366 as Buyers Defend Key Support Level